Education Center

Improved survival in liposarcoma

Publish date: September 30, 2018

 

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel .

Recommended Reading

ctDNA profiles pre- and posttreatment KIT mutations in GIST
MDedge Hematology and Oncology
Rapid drug alteration a bust in metastatic GIST
MDedge Hematology and Oncology
Adjuvant chemotherapy benefits high-risk sarcoma patients
MDedge Hematology and Oncology
Lurbinectedin shows activity against relapsed Ewing’s
MDedge Hematology and Oncology
Novel molecular assay: Promising results in bone and soft tissue tumor evaluation
MDedge Hematology and Oncology
Addressing the rarity and complexities of sarcomas
MDedge Hematology and Oncology
HIV-associated Kaposi sarcoma responds to checkpoint inhibitors
MDedge Hematology and Oncology
PARP inhibitor plus trabectedin shows promise for sarcoma
MDedge Hematology and Oncology
Chromoplexy linked to aggressive Ewing sarcomas
MDedge Hematology and Oncology
SEAL: Selinexor extends PFS in advanced dedifferentiated liposarcoma
MDedge Hematology and Oncology